Ocugen (OCGN) Asset Utilization Ratio (2015 - 2026)
Ocugen (OCGN) reported Asset Utilization Ratio of 0.09 for Q1 2026, up 44.44% on a YoY basis from 0.06 in Q1 2025, and up 1.87% quarter-over-quarter from 0.09 in Q4 2025.
Ocugen (OCGN) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Ocugen has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.09 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 44.44% year-over-year to 0.09; the trailing twelve-month figure through Mar 2026 stood at 0.09 (up 44.44% YoY), and the FY2025 full-year result was 0.07, up 27.0% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.09, up from 0.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.16 in Q2 2024, with the low at 0.0 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.06 across 5 years, with a median of 0.07 in 2023.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 1641.66% — and 2025, when it sank 48.8%.
- Ocugen's Asset Utilization Ratio stood at 0.02 in 2022, then jumped by 291.82% to 0.09 in 2023, then tumbled by 35.21% to 0.06 in 2024, then jumped by 55.4% to 0.09 in 2025, then increased by 1.87% to 0.09 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.09 (Q1 2026), 0.09 (Q4 2025), and 0.1 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.06 |
| Dec 31, 2024 | 0.06 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 0.00 |